Fiegl H - Search Results

1

Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad.

Frenzel A, Labi V, Chmelewskij W, Ploner C, Geley S, Fiegl H, Tzankov A, Villunger A. Frenzel A, et al. Among authors: fiegl h. Blood. 2010 Feb 4;115(5):995-1005. doi: 10.1182/blood-2009-03-212670. Epub 2009 Dec 3. Blood. 2010. PMID: 19965635 Free PMC article.

2

The BH3-only protein NOXA serves as an independent predictor of breast cancer patient survival and defines susceptibility to microtubule targeting agents.

Karbon G, Haschka MD, Hackl H, Soratroi C, Rocamora-Reverte L, Parson W, Fiegl H, Villunger A. Karbon G, et al. Among authors: fiegl h. Cell Death Dis. 2021 Dec 13;12(12):1151. doi: 10.1038/s41419-021-04415-y. Cell Death Dis. 2021. PMID: 34903710 Free PMC article.

3

FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3.

Rupp M, Hagenbuchner J, Rass B, Fiegl H, Kiechl-Kohlendorfer U, Obexer P, Ausserlechner MJ. Rupp M, et al. Among authors: fiegl h. Oncogene. 2017 Nov 2;36(44):6190-6203. doi: 10.1038/onc.2017.288. Epub 2017 Sep 4. Oncogene. 2017. PMID: 28869600 Free PMC article.

4

Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer.

Hofstetter G, Berger A, Fiegl H, Slade N, Zorić A, Holzer B, Schuster E, Mobus VJ, Reimer D, Daxenbichler G, Marth C, Zeimet AG, Concin N, Zeillinger R. Hofstetter G, et al. Among authors: fiegl h. Oncogene. 2010 Apr 1;29(13):1997-2004. doi: 10.1038/onc.2009.482. Epub 2010 Jan 18. Oncogene. 2010. PMID: 20101229

5

Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients.

Goebel G, Berger R, Strasak AM, Egle D, Müller-Holzner E, Schmidt S, Rainer J, Presul E, Parson W, Lang S, Jones A, Widschwendter M, Fiegl H. Goebel G, et al. Among authors: fiegl h. Br J Cancer. 2012 Jan 3;106(1):189-98. doi: 10.1038/bjc.2011.510. Epub 2011 Nov 22. Br J Cancer. 2012. PMID: 22108517 Free PMC article.

6

Polymorphisms in the gene regions of the adaptor complex LAMTOR2/LAMTOR3 and their association with breast cancer risk.

De Araujo ME, Erhart G, Buck K, Müller-Holzner E, Hubalek M, Fiegl H, Campa D, Canzian F, Eilber U, Chang-Claude J, Coassin S, Haun M, Kedenko L, Paulweber B, Reitsamer R, Himmel I, Flesch-Janys D, Lamina C, Kronenberg F, Huber LA, Kloss-Brandstätter A. De Araujo ME, et al. Among authors: fiegl h. PLoS One. 2013;8(1):e53768. doi: 10.1371/journal.pone.0053768. Epub 2013 Jan 16. PLoS One. 2013. PMID: 23341997 Free PMC article.

7

Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancer.

Wieser V, Tsibulak I, Degasper C, Welponer H, Leitner K, Parson W, Zeimet AG, Marth C, Fiegl H. Wieser V, et al. Among authors: fiegl h. Cancer Sci. 2019 Mar;110(3):1117-1126. doi: 10.1111/cas.13955. Epub 2019 Feb 16. Cancer Sci. 2019. PMID: 30697874 Free PMC article.

8

The miR-34 family and its clinical significance in ovarian cancer.

Welponer H, Tsibulak I, Wieser V, Degasper C, Shivalingaiah G, Wenzel S, Sprung S, Marth C, Hackl H, Fiegl H, Zeimet AG. Welponer H, et al. Among authors: fiegl h. J Cancer. 2020 Jan 13;11(6):1446-1456. doi: 10.7150/jca.33831. eCollection 2020. J Cancer. 2020. PMID: 32047551 Free PMC article.

9

Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer.

Reimer D, Hubalek M, Kiefel H, Riedle S, Skvortsov S, Erdel M, Hofstetter G, Concin N, Fiegl H, Müller-Holzner E, Marth C, Altevogt P, Zeimet AG. Reimer D, et al. Among authors: fiegl h. Oncogene. 2011 Sep 22;30(38):4038-49. doi: 10.1038/onc.2011.119. Epub 2011 Apr 25. Oncogene. 2011. PMID: 21516127

10

KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients.

Kammerer S, Sokolowski A, Hackl H, Platzer D, Jahn SW, El-Heliebi A, Schwarzenbacher D, Stiegelbauer V, Pichler M, Rezania S, Fiegl H, Peintinger F, Regitnig P, Hoefler G, Schreibmayer W, Bauernhofer T. Kammerer S, et al. Among authors: fiegl h. Oncotarget. 2016 Dec 20;7(51):84705-84717. doi: 10.18632/oncotarget.13224. Oncotarget. 2016. PMID: 27835900 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters